VHCP Management III, LLC, 10% Owner at Oruka Therapeutics, Inc. (ORKA), bought 245,190 shares at $11.44 ($2.8M) on 2025-02-14, disclosed to the SEC on 2025-02-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.90 | 574 | $6K | 0.2% |
| 2 | $10.95 | 9,593 | $105K | 3.7% |
| 3 | $10.95 | 9,593 | $105K | 3.7% |
| 4 | $11.86 | 8,971 | $106K | 3.8% |
| 5 | $11.86 | 8,971 | $106K | 3.8% |
| 6 | $11.63 | 14,950 |
| $174K |
| 6.2% |
| 7 | $11.63 | 14,950 | $174K | 6.2% |
| 8 | $11.44 | 88,794 | $1.0M | 36.2% |
| 9 | $11.44 | 88,794 | $1.0M | 36.2% |
| Total | $11.45 avg | 245,190 | $2.8M | 100% |
| Filing → |
| BLPH | BUY | 2018-09-17 | $252K | — | Filing → |